Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

50% or greater reduction in seizure frequency · people with focal epilepsy

Losigamone probably leads to higher 50% or greater reduction in seizure frequency compared with placebo (moderate certainty).

1 finding from 1 review

Losigamone add‐on therapy for focal epilepsy 2019 · Cochrane Headline outcomes only
RR 1.76 [1.14, 2.72]
2 studies · 467 participants
Moderate